Atlas Trials

A Phase II Study of SHR-A1811 Combined With Radiotherapy in HER2-positive and HER2-low Breast Cancer Brain Metastases

Clinical trial NCT06975462 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06975462
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Breast Cancer Metastatic
Start date
2025-06-01
Primary completion
2027-06-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.